Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Balsevich, Georgia ^a   Häusl, Alexander S ^a   Meyer, Carola W ^b   Karamihalev, Stoyo ^a   Feng, Xixi ^a   Pöhlmann, Max L ^a   Dournes, Carine ^a   Uribe Marino, Andres ^a   Santarelli, Sara ^a   Labermaier, Christiana ^a   Hafner, Kathrin ^a   Mao, Tianqi ^a   Breitsamer, Michaela ^c   Theodoropoulou, Marily ^a   Namendorf, Christian ^a   Uhr, Manfred ^a   Paez Pereda, Marcelo ^a   Winter, Gerhard ^c   Hausch, Felix ^d   Chen, Alon ^a   Tschöp, Matthias H ^b   Rein, Theo ^a   Gassen, Nils C ^a   Schmidt, Mathias V ^a   more..

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG; AKT2 PROTEIN, MOUSE; GLUCOSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN KINASE B; SLC2A4 PROTEIN, MOUSE; TACROLIMUS BINDING PROTEIN 5; TBC1D4 PROTEIN, MOUSE;

ANTAGONISM; CELLS AND CELL COMPONENTS; GENE EXPRESSION; HOMEOSTASIS; MEMBRANE; MUSCLE; PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CELL MEMBRANE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; ENZYME REGULATION; FEEDING BEHAVIOR; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; IMMUNOPRECIPITATION; INDIRECT CALORIMETRY; INSULIN SIGNALING; INSULIN TOLERANCE TEST; LIPID DIET; MALE; METABOLISM; MOUSE; MYOTUBE; NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; RESTING METABOLIC RATE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; WEIGHT GAIN; WEIGHT REDUCTION; ACTIVE TRANSPORT; ANIMAL; BIOLOGICAL MODEL; BODY WEIGHT GAIN; C57BL MOUSE; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; PHOSPHORYLATION; PHYSIOLOGICAL STRESS; SKELETAL MUSCLE CELL;

MUS;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DIET, HIGH-FAT; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUSCLE FIBERS, SKELETAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TACROLIMUS BINDING PROTEINS; WEIGHT GAIN;

EID: 85034977140     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-01783-y     Document Type: Article

References (56)

1. Ratajczak, T., Cluning, C. & Ward, B. K. Steroid receptor-associated immunophilins: A gateway to steroid signalling. Clin. Biochem. Rev. 36, 31-52 (2015).
2. Denny, W. B., Valentine, D. L., Reynolds, P. D., Smith, D. F. & Scammell, J. G. Squirrel monkey immunophilin {FKBP}51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141, 4107-4113 (2000).
3. Wochnik, G. M. et al. {FK}506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 280, 4609-4616 (2005).
4. Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C. & Jansen, M. Glucocorticoid-induced increase in lymphocytic {FKBP}51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab 88, 277-284 (2003).
5. Jääskeläinen, T., Makkonen, H. & Palvimo, J. J. Steroid up-regulation of FKBP51 and its role in hormone signaling. Curr. Opin. Pharmacol. 11, 326-331 (2011).
6. Riggs, D. L. et al. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO. J. 22, 1158-1167 (2003).
7. Zannas, A. S., Wiechmann, T., Gassen, N. C. & Binder, E. B. Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology 41, 261-274 (2016).
8. Karalis, K. P. et al. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS. J. 276, 5747-5754 (2009).
9. Balsevich, G. et al. Interplay between diet-induced obesity and chronic stress in mice: potential role of FKBP51. J. Endocrinol. 222, 15-26 (2014).
10. Guarnieri, D. J. et al. Gene profiling reveals a role for stress hormones in the molecular and behavioral response to food restriction. Biol. Psychiatry 71, 358-365 (2012).
11. Scharf, S. H., Liebl, C., Binder, E. B., Schmidt, M. V. & Muller, M. B. Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS ONE 6, e16883 (2011).
12. Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA 101, 6062-6067 (2004).
13. Hartmann, I. B. et al. The FKBP5 polymorphism rs1360780 is associated with lower weight loss after bariatric surgery: 26 months of follow-up. Surg. Obes. Relat. Dis. 12, 1554-1560 (2016).
14. Pereira, M. J. et al. FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance. Metabolism 63, 1198-1208 (2014).
15. Stechschulte, L. A. et al. FKBP51 null mice are resistant to diet-induced obesity and the PPARγ agonist rosiglitazone. Endocrinology 157, 3888-3900 (2016).
16. Pei, H. et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259-266 (2009).
17. Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBbeta). Science 292, 1728-1731 (2001).
18. Taniguchi, C. M., Emanuelli, B. & Kahn, C. R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96 (2006).
19. Zannas, A. S., Balsevich, G. & Gassen, N. C. The emerging role of FKBP5 in the regulation of metabolism and body weight. Surg. Obes. Relat. Dis. 12, 1560-1561 (2016).
20. Gaali, S. et al. Selective inhibitors of the FK506-binding protein 51 by induced fit. Nat. Chem. Biol. 11, 33-37 (2015).
21. Gassen, N. C. et al. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans. PLoS Med. 11, e1001755 (2014).
22. Hartmann, J. et al. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62, 332-339 (2012).
23. Touma, C. et al. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 70, 928-936 (2011).
24. Zimmermann, P. et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am. J. Psychiatry 168, 1107-1116 (2011).
25. Klengel, T. et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 16, 33-41 (2013).
26. Hartmann, J. et al. Pharmacological inhibition of the psychiatric risk factor FKBP51 Has anxiolytic properties. J. Neurosci. 35, 9007-9016 (2015).
27. Tamashiro, K. L., Sakai, R. R., Shively, C. A., Karatsoreos, I. N. & Reagan, L. P. Chronic stress, metabolism, and metabolic syndrome. Stress 14, 468-474 (2011).
28. Sano, H. et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278, 14599-14602 (2003).
29. Fabian, A. K. et al. InterAKTions with FKBPs-mutational and pharmacological exploration. PLoS ONE 8, e57508 (2013).
30. Storer, C. L., Dickey, C. A., Galigniana, M. D., Rein, T. & Cox, M. B. FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol. Metab. 22, 481-490 (2011).
31. Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D. & Enoch, M. A. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35, 1674-1683 (2010).
32. Mehta, D. et al. Using polymorphisms in {FKBP}5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 68, 901-910 (2011).
33. Binder, E. B. et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291-1305 (2008).
34. Maiarù, M. et al. The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling. Sci. Transl. Med. 8, 1-11 (2016).
35. Romano, S. et al. FKBP51 employs both scaffold and isomerase functions to promote NF-kappaB activation in melanoma. Nucleic Acids Res. 43, 6983-6993 (2015).
36. Sinars, C. R. et al. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc. Natl Acad. Sci. USA 100, 868-873 (2003).
37. Gassen, N. C. et al. FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications. Mol. Psychiatry 21, 277-289 (2016).
38. Jiang, W. et al. FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway. Neoplasia 10, 235-243 (2008).
39. Chen, W. S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 (2001).
40. Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F. & Birnbaum, M. J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352 (2001).
41. Garofalo, R. S. et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBb. J. Clin. Invest. 112, 197-208 (2003).
42. Kramer, H. F. et al. AS160 regulates insulin-and contraction-stimulated glucose uptake in mouse skeletal muscle. J. Biol. Chem. 281, 31478-31485 (2006).
43. DeFronzo, R. A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren, J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type {II}) diabetes mellitus. J. Clin. Invest 76, 149-155 (1985).
44. Zierath, J. R. & Wallberg-Henriksson, H. From receptor to effector: insulin signal transduction in skeletal muscle from type {II} diabetic patients. Ann. N. Y. Acad. Sci. 967, 120-134 (2002).
45. Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J. & Winder, W. W. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48, 1667-1671 (1999).
46. Treebak, J. T. et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55, 2051-2058 (2006).
47. Weinstein, S. P., Wilson, C. M., Pritsker, A. & Cushman, S. W. Dexamethasone inhibits insulin-stimulated recruitment of {GLUT}4 to the cell surface in rat skeletal muscle. Metabolism 47, 3-6 (1998).
48. Toneatto, J. et al. Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation. J. Cell Sci. 126, 5357-5368 (2013).
49. Tranguch, S. et al. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc. Natl Acad. Sci. USA 102, 14326-14331 (2005).
50. Brandl, M., Drechsler, M., Bachmann, D. & Bauer, K. H. Morphology of semisolid aqueous phosphatidylcholine dispersions, a freeze fracture electron microscopy study. Chem. Phys. Lipids. 87, 65-72 (1997).
51. Kim, D. et al. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J. Biol. Chem. 291, 22856 (2016).
52. Shefer, G. & Yablonka-Reuveni, Z. Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Methods Mol. Biol. 290, 281-304 (2005).
53. Nishiumi, S. & Ashida, H. Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci. Biotechnol. Biochem. 71, 2343-2346 (2007).
54. Kong, D. et al. Overexpression of mitofusin 2 improves translocation of glucose transporter 4 in skeletal muscle of high-fat diet-fed rats through AMP-activated protein kinase signaling. Mol. Med. Rep. 8, 205-210 (2013).
55. Hwang, S.-I. & Han, D. K. Subcellular fractionation for identification of biomarkers: serial detergent extraction by subcellular accessibility and solubility. Methods Mol. Biol. 1002, 25-35 (2013).
56. Arch, J. R., Hislop, D., Wang, S. J. & Speakman, J. R. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int. J. Obes. 30, 1322-1331 (2006).